Skip to content

Clinical trials

Sarcoma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Country / region: United Kingdom Clear all

115 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20022
20032
20041
20052
20067
20075
20085
20093
20106
20116
20121
20133
20141
20155
201611
20178
20186
20193
20205
20217
20222
20233
20244
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed56
Recruiting20
Terminated15
Unknown status13
Active, not recruiting7
Not yet recruiting2
Suspended1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC15
Royal Marsden NHS Foundation Trust10
Eli Lilly and Company7
Children's Cancer and Leukaemia Group4
Hoffmann-La Roche4
NHS Greater Glasgow and Clyde4
The Christie NHS Foundation Trust4
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano3
GlaxoSmithKline3
Sheffield Teaching Hospitals NHS Foundation Trust3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma115
Leiomyosarcoma17
Liposarcoma17
Ovarian Neoplasms17
Fibrosarcoma15
Hemangiosarcoma15
Sarcoma, Synovial15
Histiocytoma, Malignant Fibrous14
Melanoma12
Neoplasms12

Trials

Showing 1 to 25 of 115. Each trial links to its page on Pharma Observatory.

15 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.